Literature DB >> 17508015

Persistence and adherence with antihypertensive drug therapy in a German sickness fund population.

A Höer, H Gothe, Z M Khan, G Schiffhorst, G Vincze, B Häussler.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17508015     DOI： 10.1038/sj.jhh.1002223

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN： 0950-9240            Impact factor:   3.012


× No keyword cloud information.
  10 in total

1.  Individuals at risk of beta-blocker discontinuation: a cohort study in 19,177 Chinese patients.

Authors:  Martin C S Wong; Johnny Y Jiang; Xuefen Su; Haoxiang Wang; Jin Ling Tang; Sian M Griffiths
Journal:  Clin Res Cardiol       Date:  2010-02-21       Impact factor: 5.460

2.  Persistence to antihypertensive drug treatment in Swedish primary healthcare.

Authors:  Miriam Qvarnström; Thomas Kahan; Helle Kieler; Lena Brandt; Jan Hasselström; Kristina Bengtsson Boström; Karin Manhem; Per Hjerpe; Björn Wettermark
Journal:  Eur J Clin Pharmacol       Date:  2013-07-16       Impact factor: 2.953

Review 3.  Persistence and adherence with dementia pharmacotherapy: relevance of patient, provider, and system factors.

Authors:  Colleen J Maxwell; Kathryn Stock; Dallas Seitz; Nathan Herrmann
Journal:  Can J Psychiatry       Date:  2014-12       Impact factor: 4.356

4.  Meta-analysis: impact of drug class on adherence to antihypertensives.

Authors:  Ian M Kronish; Mark Woodward; Ziad Sergie; Gbenga Ogedegbe; Louise Falzon; Devin M Mann
Journal:  Circulation       Date:  2011-04-04       Impact factor: 29.690

5.  Safety and tolerability of the direct renin inhibitor aliskiren in combination with angiotensin receptor blockers and thiazide diuretics: a pooled analysis of clinical experience of 12,942 patients.

Authors:  William B White; Robert Bresalier; Allen P Kaplan; Biff F Palmer; Robert H Riddell; Anastasia Lesogor; William Chang; Deborah L Keefe
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-03-18       Impact factor: 3.738

6.  Predictors of switching from beta-blockers to other anti-hypertensive drugs: a review of records of 19,177 Chinese patients seen in public primary care clinics in the New Territory East, Hong Kong.

Authors:  Martin Cs Wong; Harry Hx Wang; Johnny Y Jiang; Stephen Leeder; Sian M Griffiths
Journal:  Asia Pac Fam Med       Date:  2011-07-27

7.  Comparison of Different Strategies to Measure Medication Adherence via Claims Data in Patients With Chronic Heart Failure.

Authors:  Peter Ihle; Katrin Krueger; Ingrid Schubert; Nina Griese-Mammen; Natalie Parrau; Ulrich Laufs; Martin Schulz
Journal:  Clin Pharmacol Ther       Date:  2019-03-12       Impact factor: 6.875

8.  Effect of patient and treatment factors on persistence with antihypertensive treatment: A population-based study.

Authors:  Sara Malo; Isabel Aguilar-Palacio; Cristina Feja; María Jesús Lallana; Javier Armesto; María José Rabanaque
Journal:  PLoS One       Date:  2021-01-15       Impact factor: 3.240

9.  Safety and tolerability of the direct renin inhibitor aliskiren: a pooled analysis of clinical experience in more than 12,000 patients with hypertension.

Authors:  William B White; Robert Bresalier; Allen P Kaplan; Biff F Palmer; Robert H Riddell; Anastasia Lesogor; William Chang; Deborah L Keefe
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-10       Impact factor: 3.738

Review 10.  Improving outcomes in hypertensive patients: focus on adherence and persistence with antihypertensive therapy.

Authors:  William J Elliott
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-07       Impact factor: 3.738
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.